Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Pui

Showing results (401-410 of 414) with videos related to

Pageof 42
Sort By:
American Journal of Clinical Oncology|October 16, 1999
Large proportion of Epstein-Barr virus-associated small noncleaved cell lymphomas among children with non-Hodgkin's lymphoma at a single institution in Moscow, RussiaJ T Sandlund, Z I Gorban, C W Berard, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2010
Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphomaJ T Sandlund, C-H Pui, H Mahmoud, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemiaM Smith, D Arthur, B Camitta, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Clinical Pharmacology and Therapeutics|August 27, 2016
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic TraitC Liu, W Yang, D Pei, et al.
Leukemia|March 27, 2004
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcomeN A Heerema, J Harbott, S Galimberti, et al.
Leukemia|July 25, 2013
VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemiaD S Mangum, J Downie, C C Mason, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Pageof 42

Showing results (401-410 of 414) with videos related to

Sort By:
Pageof 42
American Journal of Clinical Oncology|October 16, 1999
Large proportion of Epstein-Barr virus-associated small noncleaved cell lymphomas among children with non-Hodgkin's lymphoma at a single institution in Moscow, RussiaJ T Sandlund, Z I Gorban, C W Berard, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2010
Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphomaJ T Sandlund, C-H Pui, H Mahmoud, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemiaM Smith, D Arthur, B Camitta, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Clinical Pharmacology and Therapeutics|August 27, 2016
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic TraitC Liu, W Yang, D Pei, et al.
Leukemia|March 27, 2004
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcomeN A Heerema, J Harbott, S Galimberti, et al.
Leukemia|July 25, 2013
VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemiaD S Mangum, J Downie, C C Mason, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Pageof 42